Special Report

Video Anna Yeo

STAT Plus: What really happens to drug prices when patents expire

Special Report Katie Palmer

STAT Plus: How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

Special Report Elizabeth Cooney

11 experts on why gains in cardiovascular disease are stalling and what we can do about it

Special Report Elizabeth Cooney

Heart disease experts in their own words: ‘This is solvable and this is preventable’

Exclusive Bob Herman, J. Emory Parker, Lizzy Lawrence, Tara Bannow, and Mohana Ravindranath

STAT Plus: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

Special Report Matthew Herper

Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades

Special Report Sadia Rafiquddin

There’s a knowledge gap about miscarriages in the U.S., and researchers hope to close it

Special Report Andrew Joseph

4 takeaways from STAT’s story on the development of malaria vaccines

Special Report Andrew Joseph

Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers

Special Report Ashley Smart — Undark

5 takeaways from the Human Genome Project investigation

Special Report Ashley Smart — Undark

The untold story of the Human Genome Project: How one man’s DNA became a pillar of genetics

Special Report Andrew Joseph, Rachel Cohrs Zhang, Helen Branswell, and Megan Molteni

Three months into bird flu outbreak in U.S. dairy cows, experts see deep-rooted problems in response

Video Anna Yeo

STAT Plus: How pharmacy benefit managers influence drug pricing

Video Anna Yeo

STAT Plus: The role of PBMs, patents, and public health in drug pricing

Special Report Lizzy Lawrence

STAT Plus: How a device maker inundated pain patients with unwanted batteries and surprise bills

Special Report Anissa Durham

New obesity drugs are seemingly everywhere. Black Americans feel left out

Special Report Anissa Durham

Black voices, Black bodies: Life in the age of Ozempic

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

Special Report Rachel Cohrs Zhang

STAT Plus: Texas taxpayers wanted to help the poor get health care. Instead, they’re funding a medical school at a wealthy university

Special Report Brittany Trang

STAT Plus: Gene therapy offered this 7-year-old freedom. The price: a grueling year

Special Report Megan Molteni

New gene therapies confront many sickle cell patients with an impossible choice: a cure or fertility

Special Report Tara Bannow

HCA doctors say its cost-cutting is endangering Appalachian patients — a warning for the whole U.S. health care system

Special Report Angus Chen

STAT Plus: Colon cancer prevention paradox: Higher-risk patients pay more for colonoscopy

Special Report Jonathan Wosen

STAT Plus: Life scientists’ flight to biotech labs stalls important academic research

Special Report Mario Aguilar

STAT Plus: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope

Special Report Andrew Joseph

STAT Plus: Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again

Special Report Eric Boodman

How a conservative, gun-toting doctor defended abortion access in Appalachia

Special Report Sadia Rafiquddin

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

Special Report Bob Herman, J. Emory Parker, Adam Feuerstein, Lizzy Lawrence, and Mohana Ravindranath

STAT Plus: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows